The COVID-19 pandemic has shown how crucial it is for pharmaceutical and related life science players to be present on both sides of the Atlantic. If that alone is not enough of a challenge, BREXIT has made the UK no longer a suitable place to cover the European market, neither from a regulatory nor from a logistical standpoint.
So where to be in Europe and access market, talent, critical players, development support and re-locate key-staff? The answer is Vienna!
Please join our upcoming industry roundtable event, including special guests; Robin Rumler, Country Manager of Pfizer Corporation Austria, and Gloria Esposito, CEO of AUSTRIANNI as well as experts both - from Austria and the United States, who will put a spotlight on the Viennese ecosystem in the field of Life Sciences.
In less than one hour, we will take you on a virtual tour to one of the most rising stars of the European pharma and life science landscape. No longer a hidden champion, but still worth discovering, Vienna is full of local business spirit, research & development as well as regulatory and localization advantages. This innovative hub is home to over 550 companies including; Boehringer Inglheim, Octapharma, Ottobock and Siemens - to name a few – all of whom have made Vienna their home with many expanding their business facilities.
Learn from the experts why and how this happened and explore first hand networking & business expansion opportunities with the Vienna Life Science Community.
Julia Rauner Guerrero
Counselor for Commercial Affairs | U.S. Embassy in Austria
Country Manager | Pfizer Corporation Austria
CEO | Austrianni
Austrian Trade Commissioner | Advantage Austria New York
Managing Director | LISAvienna
Regional Manager USA & Canada | Vienna Business Agency
Managing Director & Founder | AHP International Inc.
During the interactive event, questions are welcome and can be posed.